Special Issue "Atmospheric Pollution Effect on Human Health: Analysis on Occupational Risks, Aeroallergens and Allergic Asthma"
Deadline for manuscript submissions: 1 March 2021.
Interests: occupational health; workplace allergy; aeroallergen monitoring; biomarkers of exposure and effect
The prevalence of allergic, and non-allergic, asthma has been increasing, with serious implications for sufferers’ health, quality-of-life and employment. Workplace allergen exposures, presentation of allergic symptoms and the development of allergic asthma have been identified through clinical and workplace studies, and occupational health surveillance schemes. The spread of aeroallergens outside of the workplace has also caused outbreaks of allergic asthma within the nearby general population.
The role of IgE-related sensitisation to inhaled allergenic proteins in allergic asthma is understood. However, factors such as atopy status. smoking history, allergen cross-reactivities, non-inhalation routes of sensitisation and modifying co-exposures suggest that the relationship between occupational exposure and the development of allergic asthma is not simple. Haptenisation of endogenous proteins by reactive low molecular weight chemicals can also lead to allergic asthma, although the industrially important isocyanates cause an “allergic-type asthma” without obvious IgE involvement.
Controlling aeroallergen levels reduces the asthma risk, but requires the capability to quantify exposure and thus understand those activities producing significant airborne allergen. A better understanding of the journey from allergen exposure, sensitisation, respiratory inflammatory responses, to the development and diagnosis of work-related allergic asthma is also crucial, as is the identification of risks from “new allergens” in the changing world of work in both developed and developing countries.
This special issue welcomes workplace, laboratory, clinical and case studies, as well as pertinent reviews on the above issues.
Dr. Howard J. Mason
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Aeroallergen measurement
- Aeroallergen characterisation
- Workplace exposures
- Exposure control
- Prevalences of sensitisation and allergic symptoms
- Biomarkers of lung inflammation
- Diagnosis of work-related allergic asthma
- Novel occupational allergens